Population-specific Interaction Risk

Population-Specific Interaction Risk is a pharmacological risk assessment construct that identifies and quantifies the likelihood of adverse drug-drug interactions within a defined demographic or genetic population subgroup, differentiating it from general interaction risk by incorporating population-level variables such as age, sex, ethnicity, or comorbid conditions.

3

Publications

129

Citations

8

Authors

5

Institutions

Publications per year

2017–2026

0

Authors

8

  1. GT
    Gianluca Trifirò

    University of Messina, Italy

    1 publications · 38 citations

    1

    h-index

  2. MD
    Michael D. Hogan

    National Institute of Environmental Health Sciences, United States

    1 publications · 76 citations

    1

    h-index

  3. LL
    Lawrence L. Kupper

    University of North Carolina at Chapel Hill, United States

    1 publications · 76 citations

    1

    h-index

  4. RS
    Ravi Sadasivuni

    Mississippi State University, United States

    1 publications · 15 citations

    1

    h-index

  5. WH
    William H. Cooke

    United States Army Institute of Surgical Research, United States

    1 publications · 15 citations

    1

    h-index

1–5 of 8

Venues

  1. American Journal of Epidemiology

    AJE · 1 publications · 76 citations

    1

    h-index

  2. Ecological Modelling

    1 publications · 15 citations

    1

    h-index

  3. European Journal of Clinical Pharmacology

    1 publications · 38 citations

    1

    h-index

  4. The American Journal of Managed Care

    AJMC · 1 publications · 11 citations

  5. Hypertension

    1 publications · 13 citations

1–5